Women Beyond Walls makes a compelling case for the need to resource work with and for women and girls impacted by the criminal legal system, including as a result of drug criminalisation.
IDPC presents key research on how the Committee on NGOs has effectively restricted civic space for drug NGOs wishing to engage in UN proceedings, and offers key recommendations for member states as they are preparing to elect new members of the Committee on NGOs in April 2022.
The NZ Drug Foundation's analysis zooms into key questions such as changes in the domestic legal framework, impact on social equity and harm reduction.
The Forum provided a space for UN, state and civil society representatives to consider how best to progress health, human rights and development in relation to drug policies.
The American Medical Association calls for increased access to healthcare and harm reduction efforts as part of a response to the growing overdose death rates in the United States.
Shaleen Title lays out a set of policy proposals to promote the growth of a diverse and competitive market, centring consumers and public health while building on effective equity programs already at work in state markets.
Handanagic et al. provide updated prevalence estimates of HIV infection and behaviours associated with HIV infection since the last NHBS survey among people who inject drugs in 2015, and represents a snapshot of the HIV prevention landscape for people who inject drugs before the COVID-19 pandemic.
Gabri et al. conclude that changes in cannabis legislation do not have an impact on the prevalence of recreational cannabis use among youth and young adults in Europe.
Chiedozie Arum et. al. conclude that homelessness and unstable housing are associated with increased risk of HIV and HCV acquisition among people who inject drugs.
